HbA1C and Haemoglobin Variant Analysers

A Contract Award Notice
by UNIVERSITY HOSPITALS PLYMOUTH NHS TRUST

Source
OJEU
Type
Contract (Supply)
Duration
7 year (est.)
Value
£1M
Sector
INDUSTRIAL
Published
26 Feb 2021
Delivery
To 26 Feb 2028 (est.)
Deadline
n/a

Concepts

Location

Trusts within the boundaries of NHS South West

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

HbA1C and Haemoglobin Variant Analysers and Associated Consumables and Reagents.

Total Quantity or Scope

The requirement is for a fully automated analytical platform capable of rapidly and accurately performing Haemoglobin A1C and haemoglobin variant measurements for Diabetes' screening and monitoring, Antenatal Haemoglobinpathy screening and Haemoglobin variant detection. The contract will be 5 years with an option to extend for a further 2 years. The contract value is estimated around £1.5million in total for the Trusts involved. It is the intention of the Trusts to novate the award of this contract into the Pathology Managed Laboratory Service contracts in this region, currently with Roche Diagnostics Ltd and Abbott Laboratories Ltd. By responding to the tender you are confirming your acceptance for the awarded contract to be novated.

Award Detail

1 Sebia (Surrey)
  • HbA1C and Haemoglobin Variant Analysers
  • Reference: 1
  • Num offers: 4
  • Value: £1,000,000

Award Criteria

PRICE _

CPV Codes

  • 38434520 - Blood analysers
  • 33124100 - Diagnostic devices
  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)
  • 85111800 - Pathology services
  • 85111810 - Blood analysis services

Indicators

  • Award on basis of price.

Reference

Domains